Citation: Bj. Albertson et al., An investigation on the use of removal-diffusion theory for BNCT treatmentplanning: A method for determining proper removal-diffusion parameters, MED PHYS, 28(9), 2001, pp. 1898-1904
Citation: Jf. Evans et al., Absorbed dose estimates to structures of the brain and head using a high-resolution voxel-based head phantom, MED PHYS, 28(5), 2001, pp. 780-786
Authors:
Woollard, JE
Albertson, BJ
Reed, MK
Blue, TE
Capala, J
Gupta, N
Gahbauer, RA
Citation: Je. Woollard et al., A comparison of neutron beams for BNCT based on in-phantom neutron field assessment parameters, MED PHYS, 28(2), 2001, pp. 184-193
Citation: Te. Blue et Je. Woollard, Predictions of a stochastic model of bone marrow cell survival in high dose rate radiation fields with arbitrary neutron to gamma-ray absorbed dose rate ratios, MED PHYS, 27(10), 2000, pp. 2385-2392
Citation: Mc. Dobelbower et al., Experimental verification of in-phantom calculations for an accelerator-based neutron source for boron neutron capture therapy, MED PHYS, 26(3), 1999, pp. 376-380
Authors:
Lunato, AJ
Wang, JH
Woollard, JE
Anisuzzaman, AKM
Ji, WH
Rong, FG
Ikeda, S
Soloway, AH
Eriksson, S
Ives, DH
Blue, TE
Tjarks, W
Citation: Aj. Lunato et al., Synthesis of 5-(carboranylallkylmercapto)-2 '-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2, J MED CHEM, 42(17), 1999, pp. 3378-3389
Authors:
Reed, MK
Dobelbower, MC
Woollard, JE
Blue, TE
Citation: Mk. Reed et al., Mixed-field dosimetry measurement of a target assembly for an accelerator-based neutron source for boron neutron capture therapy, NUCL INST A, 419(1), 1998, pp. 160-166